Guidelines: DEGRO Guidelines (Germany)

forproviders forpolicymakers germanycountry Go back to Germany page

Primary purpose: To establish evidence-based practices for the use of stereotactic radiotherapy and radiosurgery.

Sponsor, manager or home institution: DEGRO.

Type of information: Detailed protocols and evidence-based recommendations for conducting stereotactic radiotherapy and radiosurgery, focusing on specific conditions like brain metastases, early-stage non-small cell lung cancer (NSCLC), primary and secondary liver cancer, renal and pancreatic cancer, and ventricular tachycardia. These include best practices for treatment planning, dosing, patient selection, and outcomes assessment. medical procedures; diagnosis. Click here to learn more.

Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C69-C72: Eye and brain cancer; C64-C68: Urinary system cancers; C76-C80: Cancers of unknown or unspecified areas. Click here to learn more.

Access to information: Click here to access.

Esophagus Stomach Small intestine Large intestine Rectum Anus Liver Gallbladder Bile ducts Pancreas Colon Lung Trachea Bronchi Pleura Mediastinum Eye Brain Spinal cord Kidney Ureter Bladder Urethra Peritoneum Pericardium Retroperitoneum Mesothelium dataOwner::DEGRO availableVariable::medical procedures availableVariable::diagnosis hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas